Mumbai: Healthcare-focused private equity firm SomersIndus Capital Partners on Monday said it has closed fundraising for its third fund at close to $288 million, exceeding its initial target of $250 million, with a focus on healthcare in tier I and tier II cities.
The Mumbai-based fund will invest in businesses delivering affordable and accessible care across healthcare delivery, pharmaceuticals, medical devices, diagnostics and allied segments, the firm said in a release.
The latest round saw participation from development finance institutions, global investment firms, domestic financial institutions, insurance companies, funds of funds, family offices and impact investors across Europe, the United States and Southeast Asia.
“The successful fund raise is a strong endorsement of our strategy and execution capabilities,” said Avinash Kenkare, Partner, Somerset Indus Capital Partners.
The firm said strong participation from existing investors, alongside commitments from new marquee LPs, underscores continued confidence.
“Fund III positions us to deepen our presence in underserved markets and partner with entrepreneurs building scalable healthcare platforms. We remain committed to delivering measurable impact alongside sustainable financial returns,” said Mayur Sirdesai, Partner, Somerset Indus Capital Partners.
Somerset typically invests between $15 million and $40 million per portfolio company and, through co-investment syndication with its limited partner (LP) network, can participate in larger transactions in the range of $60-80 million.
The additional capital will support opportunities in preventive care and outpatient department (OPD)-linked insurance, healthcare financing, embedded insurance solutions, value-driven generics, India-focused medical technology innovation and diagnostics platforms aimed at improving access beyond metro markets, the company said.
Through Fund III, Somerset has already made three investments, including Kerala-based medical equipment firm Cyrix Healthcare, pharmaceutical packaging company Printmann Offset and Bengaluru-based hospital chain NU Hospitals.
The firm said its earlier funds have delivered strong performance, with Fund I has returned four times the total capital contributed by the investors, while Fund II is progressing toward exits, with its first realisation completed in September 2025 at around four times return on total investment, said the company.
Founded in 2011, Somerset Indus Capital Partners manages assets of around $500 million across three funds.
